ArticleThe oncologist2026

Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancer.

Lingling Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.